Company news
Microba Life Sciences Limited news in 2022
Microba Life Sciences Limited's news releases, calls and decks from 2022, newest first.
SYNLAB Agreements Signed in Italy and Portugal
December 7, 2022
Sonic Investment & Partnership Investor Presentation
November 28, 2022
Sonic Acquires 19.9% Microba Stake and Enters Partnership
November 28, 2022
Microba receives $2.62m R&D Tax Incentive refund
October 31, 2022
Q1 FY23 Quarterly Activities Report & Appendix 4C
October 26, 2022
Microba, SYNLAB Extend & Expand Distribution
October 19, 2022
Therapeutic Program Advancement
August 30, 2022
Investor Presentation - FY22 Update Annual Results
August 29, 2022
Q4 FY22 Quarterly Activities Report & Appendix 4C
July 19, 2022
G42 Healthcare Partnership Commences Operation
June 27, 2022
Microba & Ginkgo Commence Therapeutics Program
June 7, 2022
Partnership signed with nib-backed Midnight Health
May 25, 2022
Microba Accelerates Cancer Program
May 5, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 17 slides · Nov 29, 2022
- Shareholder Meeting (November 2022)
Shareholder meeting · 18 slides · Nov 25, 2022
- Q1 FY23 Earnings Presentation
Earnings · 16 slides · Oct 31, 2022
- 11th Annual Australian Microcap Investment Conference (October 2022)
Conference · 15 slides · Oct 17, 2022
- FY2022 Earnings Presentation
Earnings · 28 slides · Aug 30, 2022
- 3rd International World of Microbiome Conference 2022
Conference · 15 slides · Apr 29, 2022
- Investor Presentation (April 2022)
Investor deck · 45 slides · Apr 6, 2022